At Stanford Medicine, Catalyst accelerates bold innovations with funding, incubation support, network connections, and more to drive real-world, global impact. Swift Bio joined Catalyst in May 2024 as one such venture. Photo caption: SWIFT Bio’s leaders John Gorzynski, DVM, PhD, and Sneha Goenka, PhD, with Euan Ashley, MD, PhD at the Ashley Lab.  Led by Chief Scientific Officer, John Gorzynski, DVM, PhD (Stanford ’21) and Chief Executive Officer, Alex Johnson, Swift Bio is an

Catalyst Innovator Dr. Helen Bronte-Stewart, a Stanford Medicine professor of neurology, has dedicated her career to understanding how the brain controls movement and what happens when that process breaks down. As the global lead investigator of an international clinical trial, she spearheaded the development of an adaptive deep brain stimulation (aDBS) device — essentially a pacemaker for the brain — that senses brain activity in real time and tailors electrical pulses accor

Five years is not a long time in health care innovations. It takes, on average, 10 to 15 years to bring a new drug to market and three to seven years for new medical devices. And that’s if you have the funding and know what you’re doing. More often than not, medical innovations tumble into the ”valley of death” between bench and bedside, never crossing from initial scientific discovery to commercial product and patient care. Five years ago, Susan Hiniker , MD, an associate pr

Learn how Stanford Medicine Catalyst is helping TrNK launch a clinic-ready therapy for solid tumors, whose stubborn defenses often thwart effective treatment. If you have an innovation that could be a good fit for Catalyst, consider applying by March 16. At Stanford Medicine, Catalyst accelerates innovations with funding, incubation support, network connections and more to drive real-world, global impact. TrNK joined Catalyst in May 2024 as one such venture. When the laborato

Kidney Pod, a Stanford Medicine Catalyst supported project, is a novel organ transplantation device which maintains organs at an optimal temperature throughout the transplantation procedure.

A project supported by Stanford Medicine Catalyst is revolutionizing patient care through pharmacogenomics — personalized prescriptions...

The AVATAR project, launched by Stanford Medicine Catalyst in May 2024, is enhancing pediatric radiotherapy by improving comfort and reducing the need for anesthesia. The innovation has been deployed to 20 global sites in just one year.

Filling an unmet need for Parkinson’s disease The number of people living with Parkinson's disease (PD) globally has doubled in the past...

Promising ideas and solutions to transform health care locally and globally are plentiful at Stanford Medicine and just waiting for the...

The number of people living with Parkinson's disease globally has doubled in the past 25 years. Yet the treatment and monitoring of the...

The use of molecularly specific radiolabeled drugs to both detect and treat cancer – termed “theragnostics” – is experiencing...

Stanford Medicine Catalyst helped the CellBeacon team bring to life a new innovation that boosts the effectiveness of antibody-drug...

Across Stanford Medicine, promising ideas and solutions are plentiful and just waiting for the right support and resources to take them...

Stanford Medicine Catalyst, Stanford Medicine’s flagship innovation program to support inventors across the Stanford community in...

Diatiro, a company formed out of Catalyst Project Kidney Pod, has secured Seed funding, led by Engage Venture Partners , alongside...

Five of Stanford Medicine’s most promising innovations have recently been selected as Stanford Medicine Catalyst Award recipients....

( PR.com ) - PocketRN , a leading provider of virtual nursing care, today announced its acceptance as a participant in the Guiding an...

How Catalyst helped QDG scale to patient bedsides Have a health care innovation that could change the world? If so, consider applying for...

( Scispot.com ) In the vast world of biotechnology, there are passionate individuals who strive to make a difference in the lives of...

Within the Stanford Medicine Catalyst program, Stanford innovators aim to solve an array of  problems in health and medicine: Some fight...